http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 24 Feb 2025 07:04:02 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Board+Changes/Atea+Pharmaceuticals+Inc.+%28AVIR%29+Appoints+Arthur+S.+Kirsch+to+its+Board/24389221.html <p>Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p><p>Mr. Kirsch is currently a Senior Advisor with Alvarez & Marsal's Life Sciences Industry Group, and over the course of his 30-year career has held numerous roles in mergers and acquisitions and equity capital markets http://www.streetinsider.com/Board+Changes/Atea+Pharmaceuticals+Inc.+%28AVIR%29+Appoints+Arthur+S.+Kirsch+to+its+Board/24389221.html Mon, 24 Feb 2025 07:04:02 -0400 AVIR KDMN LQDA http://www.streetinsider.com/Board+Changes/Atea+Pharmaceuticals+Inc.+%28AVIR%29+Appoints+Arthur+S.+Kirsch+to+its+Board/24389221.html <p>Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p><p>Mr. Kirsch is currently a Senior Advisor with Alvarez & Marsal's Life Sciences Industry Group, and over the course of his 30-year career has held numerous roles in mergers and acquisitions and equity capital markets http://www.streetinsider.com/Board+Changes/Atea+Pharmaceuticals+Inc.+%28AVIR%29+Appoints+Arthur+S.+Kirsch+to+its+Board/24389221.html Mon, 24 Feb 2025 07:04:02 -0400 AVIR KDMN LQDA http://www.streetinsider.com/Board+Changes/Atea+Pharmaceuticals+Inc.+%28AVIR%29+Appoints+Arthur+S.+Kirsch+to+its+Board/24389221.html <p>Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p><p>Mr. Kirsch is currently a Senior Advisor with Alvarez & Marsal's Life Sciences Industry Group, and over the course of his 30-year career has held numerous roles in mergers and acquisitions and equity capital markets http://www.streetinsider.com/Board+Changes/Atea+Pharmaceuticals+Inc.+%28AVIR%29+Appoints+Arthur+S.+Kirsch+to+its+Board/24389221.html Mon, 24 Feb 2025 07:04:02 -0400 AVIR KDMN LQDA http://www.streetinsider.com/Corporate+News/Atea+Pharmaceuticals+Inc.+%28AVIR%29+Appoints+Arthur+S.+Kirsch+to+its+Board/24389221.html <p>Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p><p>Mr. Kirsch is currently a Senior Advisor with Alvarez & Marsal's Life Sciences Industry Group, and over the course of his 30-year career has held numerous roles in mergers and acquisitions and equity capital markets http://www.streetinsider.com/Corporate+News/Atea+Pharmaceuticals+Inc.+%28AVIR%29+Appoints+Arthur+S.+Kirsch+to+its+Board/24389221.html Mon, 24 Feb 2025 07:04:02 -0400 AVIR KDMN LQDA http://www.streetinsider.com/Corporate+News/Atea+Pharmaceuticals+Inc.+%28AVIR%29+Appoints+Arthur+S.+Kirsch+to+its+Board/24389221.html <p>Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p><p>Mr. Kirsch is currently a Senior Advisor with Alvarez & Marsal's Life Sciences Industry Group, and over the course of his 30-year career has held numerous roles in mergers and acquisitions and equity capital markets http://www.streetinsider.com/Corporate+News/Atea+Pharmaceuticals+Inc.+%28AVIR%29+Appoints+Arthur+S.+Kirsch+to+its+Board/24389221.html Mon, 24 Feb 2025 07:04:02 -0400 AVIR KDMN LQDA http://www.streetinsider.com/Corporate+News/Atea+Pharmaceuticals+Inc.+%28AVIR%29+Appoints+Arthur+S.+Kirsch+to+its+Board/24389221.html <p>Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p><p>Mr. Kirsch is currently a Senior Advisor with Alvarez & Marsal's Life Sciences Industry Group, and over the course of his 30-year career has held numerous roles in mergers and acquisitions and equity capital markets http://www.streetinsider.com/Corporate+News/Atea+Pharmaceuticals+Inc.+%28AVIR%29+Appoints+Arthur+S.+Kirsch+to+its+Board/24389221.html Mon, 24 Feb 2025 07:04:02 -0400 AVIR KDMN LQDA http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html <p>BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p> <p>Mr. Kirsch is currently a Senior Advisor with Alvarez &amp; Marsal&apos;s Life Sciences Industry Group, and over the course of his 30-year career has http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html Mon, 24 Feb 2025 07:00:00 -0400 A.13640485 A.17804036 A.19962765 A.23647887 AVIR KDMN LQDA O.00010461 O.00067624 O.02399790 O.19919773 O.29526375 O.49059080 http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html <p>BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p> <p>Mr. Kirsch is currently a Senior Advisor with Alvarez &amp; Marsal&apos;s Life Sciences Industry Group, and over the course of his 30-year career has http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html Mon, 24 Feb 2025 07:00:00 -0400 A.13640485 A.17804036 A.19962765 A.23647887 AVIR KDMN LQDA O.00010461 O.00067624 O.02399790 O.19919773 O.29526375 O.49059080 http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html <p>BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p> <p>Mr. Kirsch is currently a Senior Advisor with Alvarez &amp; Marsal&apos;s Life Sciences Industry Group, and over the course of his 30-year career has http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html Mon, 24 Feb 2025 07:00:00 -0400 A.13640485 A.17804036 A.19962765 A.23647887 AVIR KDMN LQDA O.00010461 O.00067624 O.02399790 O.19919773 O.29526375 O.49059080 http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html <p>BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p> <p>Mr. Kirsch is currently a Senior Advisor with Alvarez &amp; Marsal&apos;s Life Sciences Industry Group, and over the course of his 30-year career has http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html Mon, 24 Feb 2025 07:00:00 -0400 A.13640485 A.17804036 A.19962765 A.23647887 AVIR KDMN LQDA O.00010461 O.00067624 O.02399790 O.19919773 O.29526375 O.49059080 http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html <p>BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p> <p>Mr. Kirsch is currently a Senior Advisor with Alvarez &amp; Marsal&apos;s Life Sciences Industry Group, and over the course of his 30-year career has http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html Mon, 24 Feb 2025 07:00:00 -0400 A.13640485 A.17804036 A.19962765 A.23647887 AVIR KDMN LQDA O.00010461 O.00067624 O.02399790 O.19919773 O.29526375 O.49059080 http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html <p>BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p> <p>Mr. Kirsch is currently a Senior Advisor with Alvarez &amp; Marsal&apos;s Life Sciences Industry Group, and over the course of his 30-year career has http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html Mon, 24 Feb 2025 07:00:00 -0400 A.13640485 A.17804036 A.19962765 A.23647887 AVIR KDMN LQDA O.00010461 O.00067624 O.02399790 O.19919773 O.29526375 O.49059080 http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html <p>BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p> <p>Mr. Kirsch is currently a Senior Advisor with Alvarez &amp; Marsal&apos;s Life Sciences Industry Group, and over the course of his 30-year career has http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html Mon, 24 Feb 2025 07:00:00 -0400 A.13640485 A.17804036 A.19962765 A.23647887 AVIR KDMN LQDA O.00010461 O.00067624 O.02399790 O.19919773 O.29526375 O.49059080 http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html <p>BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p> <p>Mr. Kirsch is currently a Senior Advisor with Alvarez &amp; Marsal&apos;s Life Sciences Industry Group, and over the course of his 30-year career has http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html Mon, 24 Feb 2025 07:00:00 -0400 A.13640485 A.17804036 A.19962765 A.23647887 AVIR KDMN LQDA O.00010461 O.00067624 O.02399790 O.19919773 O.29526375 O.49059080 http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html <p>BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p> <p>Mr. Kirsch is currently a Senior Advisor with Alvarez &amp; Marsal&apos;s Life Sciences Industry Group, and over the course of his 30-year career has http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html Mon, 24 Feb 2025 07:00:00 -0400 A.13640485 A.17804036 A.19962765 A.23647887 AVIR KDMN LQDA O.00010461 O.00067624 O.02399790 O.19919773 O.29526375 O.49059080 http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html <p>BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p> <p>Mr. Kirsch is currently a Senior Advisor with Alvarez &amp; Marsal&apos;s Life Sciences Industry Group, and over the course of his 30-year career has http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html Mon, 24 Feb 2025 07:00:00 -0400 A.13640485 A.17804036 A.19962765 A.23647887 AVIR KDMN LQDA O.00010461 O.00067624 O.02399790 O.19919773 O.29526375 O.49059080 http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html <p>BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p> <p>Mr. Kirsch is currently a Senior Advisor with Alvarez &amp; Marsal&apos;s Life Sciences Industry Group, and over the course of his 30-year career has http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html Mon, 24 Feb 2025 07:00:00 -0400 A.13640485 A.17804036 A.19962765 A.23647887 AVIR KDMN LQDA O.00010461 O.00067624 O.02399790 O.19919773 O.29526375 O.49059080 http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html <p>BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p> <p>Mr. Kirsch is currently a Senior Advisor with Alvarez &amp; Marsal&apos;s Life Sciences Industry Group, and over the course of his 30-year career has http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html Mon, 24 Feb 2025 07:00:00 -0400 A.13640485 A.17804036 A.19962765 A.23647887 AVIR KDMN LQDA O.00010461 O.00067624 O.02399790 O.19919773 O.29526375 O.49059080 http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html <p>BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p> <p>Mr. Kirsch is currently a Senior Advisor with Alvarez &amp; Marsal&apos;s Life Sciences Industry Group, and over the course of his 30-year career has http://www.streetinsider.com/Press+Releases/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html Mon, 24 Feb 2025 07:00:00 -0400 A.13640485 A.17804036 A.19962765 A.23647887 AVIR KDMN LQDA O.00010461 O.00067624 O.02399790 O.19919773 O.29526375 O.49059080 http://www.streetinsider.com/Globe+Newswire/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html <p>BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p> <p>Mr. Kirsch is currently a Senior Advisor with Alvarez &amp; Marsal&apos;s Life Sciences Industry Group, and over the course of his 30-year career has http://www.streetinsider.com/Globe+Newswire/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html Mon, 24 Feb 2025 07:00:00 -0400 A.13640485 A.17804036 A.19962765 A.23647887 AVIR KDMN LQDA O.00010461 O.00067624 O.02399790 O.19919773 O.29526375 O.49059080 http://www.streetinsider.com/Globe+Newswire/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html <p>BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p> <p>Mr. Kirsch is currently a Senior Advisor with Alvarez &amp; Marsal&apos;s Life Sciences Industry Group, and over the course of his 30-year career has http://www.streetinsider.com/Globe+Newswire/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html Mon, 24 Feb 2025 07:00:00 -0400 A.13640485 A.17804036 A.19962765 A.23647887 AVIR KDMN LQDA O.00010461 O.00067624 O.02399790 O.19919773 O.29526375 O.49059080 http://www.streetinsider.com/Globe+Newswire/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html <p>BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p> <p>Mr. Kirsch is currently a Senior Advisor with Alvarez &amp; Marsal&apos;s Life Sciences Industry Group, and over the course of his 30-year career has http://www.streetinsider.com/Globe+Newswire/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html Mon, 24 Feb 2025 07:00:00 -0400 A.13640485 A.17804036 A.19962765 A.23647887 AVIR KDMN LQDA O.00010461 O.00067624 O.02399790 O.19919773 O.29526375 O.49059080 http://www.streetinsider.com/Globe+Newswire/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html <p>BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p> <p>Mr. Kirsch is currently a Senior Advisor with Alvarez &amp; Marsal&apos;s Life Sciences Industry Group, and over the course of his 30-year career has http://www.streetinsider.com/Globe+Newswire/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html Mon, 24 Feb 2025 07:00:00 -0400 A.13640485 A.17804036 A.19962765 A.23647887 AVIR KDMN LQDA O.00010461 O.00067624 O.02399790 O.19919773 O.29526375 O.49059080 http://www.streetinsider.com/Globe+Newswire/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html <p>BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p> <p>Mr. Kirsch is currently a Senior Advisor with Alvarez &amp; Marsal&apos;s Life Sciences Industry Group, and over the course of his 30-year career has http://www.streetinsider.com/Globe+Newswire/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html Mon, 24 Feb 2025 07:00:00 -0400 A.13640485 A.17804036 A.19962765 A.23647887 AVIR KDMN LQDA O.00010461 O.00067624 O.02399790 O.19919773 O.29526375 O.49059080 http://www.streetinsider.com/Globe+Newswire/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html <p>BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the appointment of Arthur S. Kirsch to the Company’s Board of Directors, effective immediately. Mr. Kirsch has decades of experience in investment banking and capital markets, as well as extensive knowledge of the healthcare and life sciences industries.</p> <p>Mr. Kirsch is currently a Senior Advisor with Alvarez &amp; Marsal&apos;s Life Sciences Industry Group, and over the course of his 30-year career has http://www.streetinsider.com/Globe+Newswire/Atea+Pharmaceuticals+Appoints+Arthur+S.+Kirsch+to+Board+of+Directors/24389116.html Mon, 24 Feb 2025 07:00:00 -0400 A.13640485 A.17804036 A.19962765 A.23647887 AVIR KDMN LQDA O.00010461 O.00067624 O.02399790 O.19919773 O.29526375 O.49059080